Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study
Titel:
Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study
Auteur:
Kim, Kyung-Soo Han, Kyung Ah Kim, Tae Nyun Park, Cheol-Young Park, Jung Hwan Kim, Sang Yong Kim, Yong Hyun Song, Kee Ho Kang, Eun Seok Kim, Chul Sik Koh, Gwanpyo Kang, Jun Goo Kim, Mi Kyung Han, Ji Min Kim, Nan Hee Mok, Ji Oh Lee, Jae Hyuk Lim, Soo Kim, Sang Soo Kim, Tae Ho Won, Kyu Chang Lee, Ki Young Cho, Jae Hyoung Han, Ju Young Kim, So Hun Nah, Jae Jin Song, Hwa Rang Lee, Si Eun Kim, Sungrae